BridgeBio Oncology Therapeutics, Inc. Common Stock

BBOTNASDAQUSD
8.64 USD
0.24 (2.86%)AT CLOSE (11:59 AM EDT)
8.66
0.31 (3.53%)
POST MARKET (AS OF 06:43 PM EDT)
Post Market
AS OF 06:43 PM EDT
8.66
0.31 (3.53%)
🟢Market: OPEN
Open?$8.75
High?$8.92
Low?$8.41
Prev. Close?$8.40
Volume?421.3K
Avg. Volume?201.8K
VWAP?$8.66
Rel. Volume?2.09x
Bid / Ask
Bid?$7.41 × 100
Ask?$9.80 × 100
Spread?$2.39
Midpoint?$8.61
Valuation & Ratios
Market Cap?672.3M
Shares Out?80.0M
Float?27.7M
Float %?34.6%
P/E Ratio?N/A
P/B Ratio?1.64
EPS?-$1.04
Dividend?0.00%
Ex-Dividend?N/A
Technical Outlook
Loading...
Fundamental Outlook
Loading...
Short Interest
Loading...
Financial Health
Current Ratio?12.34Strong
Quick Ratio?12.34Strong
Cash Ratio?10.66Strong
Debt/Equity?0.00Low
ValuationFAIRLY VALUED
Score
67/100
P/E?
N/A
P/B?
1.64CHEAP
P/S?
186,535.99HIGH
P/FCF?
N/A
EV/EBITDA?
-3.1CHEAP
EV/Sales?
82,849.25HIGH
Returns & Efficiency
ROE?
-20.2%WEAK
ROA?
-18.5%WEAK
Cash Flow & Enterprise
FCF?$-114500000
Enterprise Value?$298.6M
Related Companies
Loading...
News
Profile
BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes. The Company operates in one operating and reportable segment within the United States, developing oncology therapies through various related development projects.
Employees
92
Market Cap
672.3M
Industry
PHARMACEUTICAL PREPARATIONS
Listed
2025-08-12
Address
256 E. GRAND AVENUE, SUITE 104
SOUTH SAN FRANCISCO, CA 94080
Phone: 857 702 0377